Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
SAGE Open Medical Case Reports|September 14, 2020
An unusual cause of polymorphic ventricular tachycardia: Acquired long QT syndrome from atypical variant of stress-induced cardiomyopathyMashael Alfarih, James C Moon, Marianna Fontana, et al.Magnetic Resonance in Medicine|May 25, 2021
Real-time deep artifact suppression using recurrent U-Nets for low-latency cardiac MRIOlivier Jaubert, Javier Montalt-Tordera, Dan Knight, et al.Echo Research and Practice|June 9, 2017
Diagnosis and assessment of dilated cardiomyopathy: a guideline protocol from the British Society of EchocardiographyThomas Mathew, Lynne Williams, Govardhan Navaratnam, et al.European Journal of Clinical Investigation|November 13, 2020
A simple echocardiographic score to rule out cardiac amyloidosisAlberto Aimo, Vladyslav Chubuchny, Giuseppe Vergaro, et al.European Journal of Heart Failure|November 24, 2023
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importanceAdam Ioannou, Muhammad U Rauf, Rishi K Patel, et al.European Journal of Heart Failure|October 18, 2024
Microvascular obstruction in cardiac amyloidosisLucrezia Netti, Adam Ioannou, Ana Martinez-Naharro, et al.Journal of the American Heart Association|February 5, 2024
Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac AmyloidosisAdam Ioannou, Christian Nitsche, Aldostefano Porcari, et al.Bioinformatics (Oxford, England)|July 27, 2024
Best practices to evaluate the impact of biomedical research software-metric collection beyond citationsAwan Afiaz, Andrey A Ivanov, John Chamberlin, et al.Arxiv|June 19, 2023
Evaluation of software impact designed for biomedical research: Are we measuring what's meaningful?Awan Afiaz, Andrey A Ivanov, John Chamberlin, et al.JAMA Cardiology|August 21, 2024
Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL AmyloidosisAldostefano Porcari, Ambra Masi, Ana Martinez-Naharro, et al.Pageof 1